Increased CD25 could be observed in both CD4+ and CD8+ T cells of patients with CLL in presence of teclistamab, which was enhanced by addition of γ-secretase inhibitor (Fig. 6A). The gene discussed is CD4; the disease is B-cell chronic lymphocytic leukemia.